Central venous access related adverse events after trabectedin infusions in soft tissue sarcoma patients; experience and management in a nationwide multi-center study

BACKGROUND: Trabectedin has shown efficacy against soft tissue sarcomas (STS) and has manageable toxicity. Trabectedin is administered through central venous access devices (VAD), such as subcutaneous ports with tunneled catheters, Hickman catheters and PICC lines. Venous access related adverse even...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Clin Sarcoma Res
Main Authors: Verboom, Michiel C., Ouwerkerk, Jan, Steeghs, Neeltje, Lutjeboer, Jacob, Martijn Kerst, J., van der Graaf, Winette T. A., Reyners, Anna K. L., Sleijfer, Stefan, Gelderblom, Hans
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5282803/
https://ncbi.nlm.nih.gov/pubmed/28163887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-017-0066-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki